Niagen Bioscience, Inc. (NAGE) Institutional Ownership

Ownership Summary

Niagen Bioscience, Inc. (NASDAQ:NAGE) has 163 institutional investors with active 13F positions as of December 2025.

• These investors held 37.1% of outstanding shares in December 2025, down from 37.2% in September 2025.
• They increased total shares held in Niagen Bioscience by 6.86% from the prior quarter, while the number of investors in NAGE increased 33.61% year over year.
• Activity in NAGE broke down as 91 buyers, 54 sellers, and 18 unchanged among 163 total holders.
• In total, institutional investors held 32.14Mn shares in Niagen Bioscience as of December 2025, up by 2.06Mn shares quarter on quarter, and up 9.07Mn shares year over year.
• As of December 31, 2025, BlackRock, Inc. held the largest stake in Niagen Bioscience with 3.87Mn shares, accounting for 4.47% of total shares outstanding.
• The biggest buyers of Niagen Bioscience for the quarter ending December 2025 included SteelPeak Wealth, LLC (3.37Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.15Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (1.22Mn), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (761.68K), Qube Research & Technologies Ltd (652.8K).
• Leading sellers of Niagen Bioscience shares for the quarter ending December 2025 were Goldman Sachs Group Inc (657.8K), Morgan Stanley (499.04K), Nuveen, LLC (368.69K), Ameriprise Financial Inc (284.35K), STATE OF WISCONSIN INVESTMENT BOARD (224.07K).
• Business Quant data shows the 10 biggest positions in Niagen Bioscience as of December 2025 are held by BlackRock, Inc. (3.87Mn), SteelPeak Wealth, LLC (3.37Mn), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (2.38Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.15Mn), Tieton Capital Management, LLC (2.03Mn), Qube Research & Technologies Ltd (1.71Mn), UBS Group AG (1.41Mn), GEODE CAPITAL MANAGEMENT, LLC (1.34Mn), RENAISSANCE TECHNOLOGIES LLC (1.33Mn), Goldman Sachs Group Inc (1.25Mn).